Remove FDA Remove Patient Advocacy Remove Prescription Drug Pricing Remove Public Health
article thumbnail

In 2023, the U.S. Will Still Be the #1 Prescription Drug Spender in the World, IQVIA Forecasts

Health Populi

Other key trends to expect leading to 2023 will be: The rise of patient advocacy roles in pharma companies. The growing adoption of artificial intelligence and machine learning by pharma companies to drive more efficient drug discovery. More philanthropic organizations targeting neglected tropical and public health diseases.